Powered by

Powered by Portfolio Grader

Revance Therapeutics (RVNC)

15.96 0.09 (0.57%) 16:11 EDT
RVNC Stock Quote Delayed 15 Minutes
  • RVNC Stock Chart

  • Historical RVNC Prices

 
Dividend & Yield:       N/A (N/A)
P/E:       -3.95
Market Cap:       587.07M
EPS:       -4.04
Volume:       241,978
Day's Range:       15.65 - 15.99
52wk Range:       15.07 - 34.20
Quotes delayed at least 20 mins.
Historical Data for RVNC
Date Open High Low Volume Close Change %
03/21/19 15.74 15.99 15.65 241,978 15.96 0.09   0.57%
03/20/19 16.32 16.34 15.82 346,184 15.87 -0.45   -2.76%
03/19/19 16.05 16.49 15.94 337,090 16.32 0.32   2.00%
03/18/19 15.48 16.10 15.07 582,924 16.00 0.55   3.56%
03/15/19 15.64 15.71 15.38 1,253,400 15.45 -0.12   -0.77%
03/14/19 15.98 16.07 15.57 486,401 15.57 -0.52   -3.23%
03/13/19 16.28 16.53 16.00 388,190 16.09 -0.14   -0.86%
03/12/19 16.24 16.37 15.99 275,811 16.23 0.05   0.31%
03/11/19 15.98 16.19 15.74 278,688 16.18 0.21   1.31%
03/08/19 16.10 16.16 15.77 300,900 15.97 -0.24   -1.48%
03/07/19 16.20 16.50 15.83 318,255 16.21 -0.04   -0.25%
03/06/19 17.12 17.34 16.18 484,839 16.25 -0.84   -4.92%
03/05/19 17.18 17.39 16.93 393,507 17.09 -0.10   -0.58%
03/04/19 17.25 17.66 16.96 331,176 17.19 0.06   0.35%
03/01/19 16.93 17.14 16.67 570,700 17.13 0.19   1.12%
02/28/19 17.20 17.75 16.58 396,012 16.94 -0.04   -0.24%
02/27/19 17.00 17.32 15.38 829,755 16.98 -0.09   -0.53%
02/26/19 17.03 17.25 16.63 627,578 17.07 0.09   0.53%
02/25/19 17.79 17.88 16.96 526,157 16.98 -0.55   -3.14%
02/22/19 17.38 17.54 17.06 388,600 17.53 0.27   1.56%
02/21/19 18.00 18.10 17.13 227,945 17.26 -0.71   -3.95%
02/20/19 17.66 18.15 17.58 490,901 17.97 0.30   1.70%
02/19/19 17.68 17.96 17.31 326,760 17.67 -0.02   -0.11%
02/15/19 17.85 17.94 17.47 352,500 17.69 -0.14   -0.79%
02/14/19 18.02 18.12 17.71 283,639 17.83 0.05   0.28%
02/13/19 17.84 17.99 17.62 270,733 17.78 -0.08   -0.45%
02/12/19 17.88 18.32 17.64 244,148 17.86 0.06   0.34%
02/11/19 17.20 17.82 16.81 330,640 17.80 0.69   4.03%
02/08/19 16.96 17.18 16.83 219,400 17.11 0.15   0.88%
02/07/19 17.09 17.39 16.79 258,453 16.96 -0.21   -1.22%
02/06/19 17.52 17.78 17.10 269,585 17.17 -0.37   -2.11%
02/05/19 16.97 17.55 16.83 582,801 17.54 0.64   3.79%
02/04/19 17.55 17.87 16.76 597,899 16.90 -0.62   -3.54%
02/01/19 17.37 17.95 16.94 1,153,700 17.52 0.25   1.45%
01/31/19 17.62 17.92 17.20 352,316 17.27 -0.37   -2.10%
01/30/19 17.06 17.72 17.06 447,447 17.64 0.59   3.46%
01/29/19 17.60 17.90 16.98 1,243,631 17.05 0.05   0.29%
01/28/19 17.13 17.21 16.56 774,234 17.00 -0.27   -1.56%
01/25/19 17.23 17.28 17.00 329,400 17.27 0.04   0.23%
01/24/19 17.16 17.37 16.88 289,274 17.23 0.05   0.29%
01/23/19 17.65 17.95 17.14 449,399 17.18 -0.30   -1.72%
01/22/19 17.77 17.91 17.05 444,283 17.48 -0.33   -1.85%
01/18/19 17.25 18.24 17.25 907,000 17.81 0.58   3.37%
01/17/19 17.78 17.89 16.76 3,435,501 17.23 -0.88   -4.86%
01/16/19 19.27 19.69 18.11 1,508,401 18.11 -2.08   -10.30%
01/15/19 19.52 20.53 19.49 228,441 20.19 0.76   3.91%
01/14/19 19.78 19.98 19.22 173,866 19.43 -0.35   -1.77%
01/11/19 19.73 19.85 19.41 144,700 19.78 0.05   0.25%
01/10/19 19.92 20.16 19.50 165,478 19.73 -0.25   -1.25%
01/09/19 19.99 20.33 19.31 393,376 19.98 0.04   0.20%
01/08/19 20.33 20.34 19.68 267,232 19.94 -0.24   -1.19%
01/07/19 20.58 20.83 20.03 403,084 20.18 -0.21   -1.03%
01/04/19 19.88 20.45 19.47 282,600 20.39 0.75   3.82%
01/03/19 19.48 19.73 19.05 159,733 19.64 0.13   0.67%
Revance Therapeutics (RVNC) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Revance Therapeutics Stock Analysis

Rating: Strong Sell

Total Grade: F

Analysis Breakdown

RVNC Stock Grade: F
Fundamental Grade: C
Quantitative Grade: F
RVNC Earnings
Earnings Growth: C
Earnings Momentum: B
Earnings Surprises: F
Analyst Earnings Revisions: A
RVNC Financial Information
Sales Growth: A
Operating Margin Growth: C
Cash Flow: C
Return on Equity: F

Revance Therapeutics Stock: Weekly View

This Week: F
Last Week: F
Two Weeks Ago: F
Get Full Report